Cytokine induced expression of programmed death ligands in human neutrophils

Immunology Letters

Volumn 129, Issue 2, 2010, Pages 100-107

  Bankey, Paul E ^a   Banerjee, Sanjib ^a   Zucchiatti, Andrea ^a   De, Mita ^a   Sleem, Rami W ^a   Lin, Chuen Fu L ^a   Miller Graziano, Carol L ^a   De, Asit K ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cytokine; Human neutrophil; ILT; PD L

Indexed keywords

CELL PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN LIKE TRANSCRIPT 2; IMMUNOGLOBULIN LIKE TRANSCRIPT 3; IMMUNOGLOBULIN LIKE TRANSCRIPT 4; IMMUNOGLOBULIN LIKE TRANSCRIPT 5; PROGRAMMED DEATH 1 LIGAND 1; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, CD; APOPTOSIS; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; NEUTROPHILS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC;

EID: 77949567485     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.01.006     Document Type: Article

References (39)

1. Nauseef W.M. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 2007, 219:88-102.
2. Herrmann J.M., Bernardo J., Long H.J., Seetoo K., McMenamin M.E., Batista E.L., et al. Sequential chemotactic and phagocytic activation of human polymorphonuclear neutrophils. Infect Immun 2007, 75:3989-3998.
3. Steinman R.M. Dendritic cells: understanding immunogenicity. Eur J Immunol 2007, 37(Suppl 1):S53-S60.
4. Adler H.S., Steinbrink K. Tolerogenic dendritic cells in health and disease: friend and foe!. Eur J Dermatol 2007, 17:476-491.
5. van Gisbergen K.P., Sanchez-Hernandez M., Geijtenbeek T.B., van Kooyk Y. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J Exp Med 2005, 201:1281-1292.
6. Megiovanni A.M., Sanchez F., Robledo-Sarmiento M., Morel C., Gluckman J.C., Boudaly S. Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes. J Leukoc Biol 2006, 79:977-988.
7. Beauvillain C., Delneste Y., Scotet M., Peres A., Gascan H., Guermonprez P., et al. Neutrophils efficiently cross-prime naive T cells in vivo. Blood 2007, 110:2965-2973.
8. Gosselin E.J., Wardwell K., Rigby W.F., Guyre P.M. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol 1993, 151:1482-1490.
9. Reinisch W., Lichtenberger C., Steger G., Tillinger W., Scheiner O., Gangl A., et al. Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo. Clin Exp Immunol 2003, 133:476-484.
10. Radsak M., Iking-Konert C., Stegmaier S., Andrassy K., Hansch G.M. Polymorphonuclear neutrophils as accessory cells for T-cell activation: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation. Immunology 2000, 101:521-530.
11. Cella M., Dohring C., Samaridis J., Dessing M., Brockhaus M., Lanzavecchia A., et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 1997, 185:1743-1751.
12. Ju X.S., Hacker C., Scherer B., Redecke V., Berger T., Schuler G., et al. Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene 2004, 331:159-164.
13. Kim-Schulze S., Seki T., Vlad G., Scotto L., Fan J., Colombo P., et al. Regulation of ILT3 gene expression by processing of precursor transcripts in human endothelial cells. Am J Transplant 2006, 6:76-82.
14. Munitz A., Bachelet I., Eliashar R., Moretta A., Moretta L., Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006, 107:1996-2003.
15. Tedla N., Bandeira-Melo C., Tassinari P., Sloane D., Samplaski M., Cosman D., et al. Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7. Proc Natl Acad Sci U S A 2003, 100:1174-1179.
16. Colonna M., Nakajima H., Navarro F., Lopez-Botet M. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 1999, 66:375-381.
17. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000, 192:1027-1034.
18. Keir M.E., Butte M.J., Freeman G.J., Sharpe A.H. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008, 26:677-704.
19. Waeckerle-Men Y., Starke A., Wuthrich R.P. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells. Nephrol Dial Transplant 2007, 22:1527-1536.
20. Liu X., Gao J.X., Wen J., Yin L., Li O., Zuo T., et al. B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med 2003, 197:1721-1730.
21. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001, 2:261-268.
22. Lehner T. Special regulatory T cell review: the resurgence of the concept of contrasuppression in immunoregulation. Immunology 2008, 123:40-44.
23. Oei E., Kalb T., Beuria P., Allez M., Nakazawa A., Azuma M., et al. Accessory cell function of airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2004, 287:L318-L331.
24. Sheth K., Friel J., Nolan B., Bankey P. Inhibition of p38 mitogen activated protein kinase increases lipopolysaccharide induced inhibition of apoptosis in neutrophils by activating extracellular signal-regulated kinase. Surgery 2001, 130:242-248.
25. Bandyopadhyay G., De A., Laudanski K., Li F., Lentz C., Bankey P., et al. Negative signaling contributes to T-cell anergy in trauma patients. Crit Care Med 2007, 35:794-801.
26. Martin U., Bock D., Arseniev L., Tornetta M., Ames R., Bautsch W., et al. The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes. J Exp Med 1997, 186:199-207.
27. Laudanski K., De A., Miller-Graziano C. Exogenous heat shock protein 27 uniquely blocks differentiation of monocytes to dendritic cells. Eur J Immunol 2007, 37:2812-2824.
28. Fanger N.A., Liu C., Guyre P.M., Wardwell K., O'Neil J., Guo T., et al. Activation of human T cells by major histocompatibility complex class II expressing neutrophils: proliferation in the presence of superantigen, but not tetanus toxoid. Blood 1997, 89:4128-4135.
29. De A.K., Miller-Graziano C.L., Calvano S.E., Laudanski K., Lowry S., Moldawer L., et al. Selective activation of peripheral blood T cell subsets by endotoxin infusion in healthy human subjects corresponds to differential chemokine activation. J Immunol 2005, 175:6155-6162.
30. Salih H.R., Wintterle S., Krusch M., Kroner A., Huang Y.H., Chen L., et al. The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans. Exp Hematol 2006, 34:888-894.
31. Tamura H., Dan K., Tamada K., Nakamura K., Shioi Y., Hyodo H., et al. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia. Clin Cancer Res 2005, 11:5708-5717.
32. Collins S.J., Ruscetti F.W., Gallagher R.E., Gallo R.C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A 1978, 75:2458-2462.
33. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997, 159:4772-4780.
34. Kanai T., Totsuka T., Uraushihara K., Makita S., Nakamura T., Koganei K., et al. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol 2003, 171:4156-4163.
35. Curiel T.J., Wei S., Dong H., Alvarez X., Cheng P., Mottram P., et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 2003, 9:562-567.
36. Iking-Konert C., Vogt S., Radsak M., Wagner C., Hansch G.M., Andrassy K. Polymorphonuclear neutrophils in Wegener's granulomatosis acquire characteristics of antigen presenting cells. Kidney Int 2001, 60:2247-2262.
37. Iking-Konert C., Ostendorf B., Sander O., Jost M., Wagner C., Joosten L., et al. Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells. Ann Rheum Dis 2005, 64:1436-1442.
38. van der Meer W., Stephen Scott C., Verlaat C., Gunnewiek J.K., Warris A. Measurement of neutrophil membrane CD64 and HLA-Dr in a patient with abdominal sepsis. J Infect 2006, 53:e43-e46.
39. Bisson-Boutelliez C., Miller N., Demarch D., Bene M.C. CD9 and HLA-DR expression by crevicular epithelial cells and polymorphonuclear neutrophils in periodontal disease. J Clin Periodontol 2001, 28:650-656.